semaglutide drug type for Weight Loss: How It Works, Comparisons, and More Focus: Demand for weight-loss drugs

Key implications: Simplified administration may improve patient uptake Broader accessibility across diverse healthcare settings Reinforces the shift toward chronic disease models in obesity care As we move forward, the focus will not only be on efficacy but also on real-world implementation, cost considerations, and long-term outcomes

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

Metabolic & Appetite Support for a Slimmer, Healthier You.

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to incomeraising questions for both Medicaid and Medicare.

Heres a quick look

We're still scheduling established patients and all aesthetic & specialty services.